Navigation Links
TELITHROMYCIN - the proven effective new drug for cap

Community acquired pneumonia other wise known as CAP has been a therapeutic challenge to most of the practising physicians. This is mainly due to the growing resistance of the bacteria causing them to the available antibiotics.

Telithromycin (Ketek), a new ketolide antibiotic, is highly effective in treating patients with pneumococcal bacteraemia associated with community-acquired pneumonia (CAP). This is a breakthrough in the field of anti microbials as pneumococcal resistance is on the rage. Dr. Thomas M. File, Jr., of Northeastern Ohio University of Medicine, Rootstown, commented that, "Currently clinicians who perceive their patients to be at risk for infection with resistant pathogens are relying on one or two classes of antimicrobials. This results in increased pressure on those classes ", and this infact is responsible for the resistance strains of this group of bacteria.

The efficacy of the drug was assessed by five clinical trials and clinical and biological outcomes was noted. Blood samples were taken before and after the therapy for both aerobic and anaerobic culture. It was found that, the overall clinical cure rate with telithromycin was 89.5% after 7 to 11 days of therapy.

Telithromycin has recently been approved by the US Food and Drug Administration for the treatment of CAP, acute bacterial exacerbation of chronic bronchitis (ABECB), and acute bacterial sinusitis (ABS) and is marketed by Aventis Pharma.
'"/>




Page: 1

Related medicine news :

1. Partial-Breast Irradiation an Unproven Therapy
2. New drug proven to tackle Type 2 Diabetes
3. Morning after pill effective up to five days after having unprotected sex
4. Distraction therapy found very effective in postoperative patients
5. Digital mammography proves effective
6. Treatment for pre-menstrual syndrome is ineffective
7. Cost-effective antibiotics for sinusitis treatment
8. An effective way to treat angina
9. Fluoride proves effective against fractures
10. Meningitis C vaccine a cost-effective success
11. An effective drug for lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... Durham, NC (PRWEB) , ... May 04, 2016 ... ... healthcare professionals in medical coding, billing and compliance. In upcoming months, AudioEducator has ... on various specialties. Every conference is designed to give complete compliance know-how and ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... ... ... Fertility Centers of New England announced today the opening of their newest location ... access to care for patients seeking fertility treatment in Maine. “We are delighted to ... Portland,” said Fertility Centers of New England President and CEO, Joseph A. Hill, M.D. ...
(Date:5/3/2016)... , ... May 04, 2016 , ... ... 40 national and global construction firms representing the Construction Industry Safety Initiative (CISI) ... forces with one purpose: to inspire everyone in the industry to be leaders ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... Business Journal, patients report dissatisfaction with numerous issues related to medical care in ... with billing, and poor bedside manner from hospital staff. Commenting on this article, ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)... May 2, 2016  While nearly three-quarters of Americans ... have on their health, only about half report taking ... the results of a new survey announced today by ... start of National Osteoporosis Month, Hologic is raising awareness ... nearly 56 million Americans. Osteoporosis is a ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
Breaking Medicine Technology: